Medpace Holdings, Inc. — Director's Dealing 2021

Oct 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-10-26

Reporting Person: GEIGER JESSE J (President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-26	Common Stock	M	10000	$28.32	Acquired	16382	Direct
2021-10-26	Common Stock	S	10000	$211.36	Disposed	6382	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-26	Employee Stock Option (Right to Buy)	$28.32	M	10000	Disposed	2024-03-15	Common Stock (10000)	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $204.53 to $214.51. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

F3: Each option vested on March 15, 2021.